News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PAKIANATHAN DEEPIKA
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/04/2023 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,132 shares
@ $0
Granted 22,044 options to buy
@ $10.95, valued at
$241.4k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,852 shares
@ $0
Granted 28,000 options to buy
@ $10.15, valued at
$284.2k
|
|
| 12/30/2021 |
4/A
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Converted 30,000 shares
@ $0
Converted 30,000 options to buy
@ $0 |
|
| 12/28/2021 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Converted 52,500 shares
@ $0
Converted 52,500 options to buy
@ $0 |
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 23,900 options to buy
@ $9.42, valued at
$225.1k
|
|
| 04/29/2021 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,828 shares
@ $0
Granted 6,000 options to buy
@ $20.35, valued at
$122.1k
|
|
| 02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2020 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,067 shares
@ $0
Granted 12,000 options to buy
@ $20.66, valued at
$247.9k
Granted 5,000 options to buy
@ $20.66, valued at
$103.3k
|
|
| 07/06/2020 |
3
| PAKIANATHAN DEEPIKA (Director) has filed a Form 3 on Theravance Biopharma, Inc. |
| 06/11/2020 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.25, valued at
$105k
|
|
| 05/26/2020 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 16,400 options to buy
@ $19.11, valued at
$313.4k
|
|
| 06/07/2019 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.43, valued at
$135.8k
|
|
| 06/03/2019 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.42, valued at
$59.6k
|
|
| 04/23/2019 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 1,991,602 shares
@ $0
Unknown transaction of 18,940 shares
@ $0 |
|
| 06/25/2018 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/20/2018 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $18.8, valued at
$319.6k
|
|
| 06/04/2018 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.15, valued at
$56.7k
|
|
| 05/25/2018 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $15.5, valued at
$232.5k
|
|
| 06/16/2017 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.18, valued at
$156.1k
|
|
| 06/13/2017 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $14.2, valued at
$156.2k
|
|
| 06/02/2017 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $3.3, valued at
$49.5k
|
|
| 05/26/2017 |
4
| PAKIANATHAN DEEPIKA (10% Owner) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $16.9, valued at
$253.5k
|
|
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Karyopharm Therapeutics Inc. |
| 06/16/2016 |
4
| PAKIANATHAN DEEPIKA (10% Owner) has filed a Form 4 on Calithera Biosciences, Inc. |
| 06/02/2016 |
4
| PAKIANATHAN DEEPIKA (10% Owner) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $29.26, valued at
$438.9k
|
|
|
|
|